Prevalence of Human Immunodeficiency Virus Type 1 p24 Antigen in U.S. Blood Donors — An Assessment of the Efficacy of Testing in Donor Screening
Open Access
- 8 November 1990
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 323 (19) , 1312-1317
- https://doi.org/10.1056/nejm199011083231905
Abstract
We performed a multicenter study in 1989 to determine whether screening whole-blood donors for human immunodeficiency virus type 1 (HIV-1) p24 antigen would improve transfusion safety by identifying carriers of the virus who are seronegative for HIV-1 antibody.This publication has 18 references indexed in Scilit:
- A model for estimating incremental benefits and costs of testing donated blood for human immunodeficiency virus antigen (HIV‐Ag)Transfusion, 1990
- Exposure of Patients to Human Immunodeficiency Virus through the Transfusion of Blood Components That Test Antibody-NegativeNew England Journal of Medicine, 1989
- Clinical Implications of Positive Tests for Antibodies to Human Immunodeficiency Virus Type 1 in Asymptomatic Blood DonorsNew England Journal of Medicine, 1989
- Transmission of Retroviruses by Transfusion of Screened Blood in Patients Undergoing Cardiac SurgeryNew England Journal of Medicine, 1989
- Epidemiologic characteristics of blood donors with antibody to human immunodeficiency virusTransfusion, 1988
- Transmission of Human Immunodeficiency Virus (HIV) by Blood Transfusions Screened as Negative for HIV AntibodyNew England Journal of Medicine, 1988
- Estimating the risks of transfusion‐associated acquired immune deficiency syndrome and human immunodeficiency virus infectionTransfusion, 1987
- Optimal volume of plasma exchange in thrombotic thrombocytopenic purpuraTransfusion, 1987
- Stages in the Progression of HIV Infection in ChimpanzeesAIDS Research and Human Retroviruses, 1987
- SEROLOGICAL MARKERS IN EARLY STAGES OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN HAEMOPHILIACSThe Lancet, 1986